This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

PetSmart, Dendreon: After-Hours Trading

NEW YORK (TheStreet) -- PetSmart (PETM) shares ticked lower late Wednesday after the Phoenix-based pet products retailer posted largely in-line results for its third quarter and gave a lukewarm outlook for the fourth quarter.

For the three months ended Sept. 30, PetSmart earned $45.6 million, or 38 cents a share, on sales of $1.4 billion, up 7.2% year-over-year. For the fourth quarter, the company forecast earnings of 71 to 75 cents a share with same-store sales growth projected in the mid-single digits. The average estimate of analysts polled by Thomson Reuters is for a profit of 73 cents a share in the December period.



The stock was last quoted at $37.50, down 2%, on volume of more than 250,000, according to Nasdaq.com. Year-to-date, the shares are up 41% based on their regular-session close at $38.28.

Meantime A-Power Energy Generation Systems (APWR) fell as well in extended trades, sliding more than 8% to $6.03 on volume of almost 60,000.

The Chinese wind turbine manufacturer postponed a planned conference call about its third-quarter results after the close, providing no explanation for the change. A-Power originally announced plans for the Nov. 18 conference call on Tuesday.

"The postponement was not due to any accounting irregularities," A-Power said in a terse press release. "The Company regrets any inconvenience that the postponement may have created."

On the plus side was Dendreon (DNDN), which gained 6% to $37.94 on volume of more than 1.1 million. The Seattle biotech was halted for much of the regular session, and then re-opened in after-hours action, surging on news that a panel of outside advisors to the Medicare program were in favor of reimbursement for the company's Provenge prostate cancer drug. NetApp (NTAP) edged higher in after-hours action, regaining some of the ground the stock lost in the regular session after its fiscal second-quarter report leaked prior to the closing bell.

The Sunnyvale, Calif.-based data storage technology company reported non-GAAP earnings of $202.7 million, or 52 cents a share, for the three months ended Oct. 31 with revenue coming in at $1.21 billion. That performance was slightly ahead of Wall Street's consensus view for a profit of 49 cents a share in the period on revenue of $1.19 billion.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs